NCT07436663 2026-02-27
SGLT2i/DPPi
Tanta University
Phase 4 Not yet recruiting
Clinical Trials
14 trialsNCT07094048 2026-01-07
CHUQUL_HO001
CHU de Quebec-Universite Laval
Phase 4 Recruiting
NCT05365230 2025-11-24
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Completed
NCT06903312 2025-07-03
ITALIC-RCC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Recruiting
NCT06834386 2025-05-01
Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients
Mayo Clinic
Phase 4 Withdrawn
NCT01468623 2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4 Terminated
NCT04687124 2020-12-29
EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -
University of Copenhagen
Phase 4 Unknown
NCT04107480 2020-07-20
PRolaCT - Three Prolactinoma RCTs
Leiden University Medical Center
Phase 4 Recruiting
NCT02451488 2020-02-10
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
Mayo Clinic
Phase 4 Completed
NCT03831633 2019-02-06
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
VIFORFRANCE
Phase 4 Unknown
NCT02034799 2018-02-26
Phase IV Bioseal Study in Brain Tumor Surgery
Ethicon, Inc.
Phase 4 Completed
NCT00496678 2013-08-09
Trial of Patient Navigation-Activation
University of Rochester
Phase 4 Completed
NCT00771966 2012-10-22
Radical Prostatectomy and Perioperative Fluid Therapy
Rigshospitalet, Denmark
Phase 4 Completed
NCT00224068 2012-03-02
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Watson Pharmaceuticals
Phase 4 Completed